論文的前半部為前言，主要是透過查詢過去的文獻，介紹3-azabicyclo[3.1.0]hexane 的衍生物作為藥物的研究價值，以及其他團隊的合成方法，並說明研究動機及目標。
後半部為介紹利用微波反應器在碘的作用下使 (Z)-3-bromo-3-phenylacrylaldehyde、3-oxo-3-phenylpropanenitrile與 Ammonium acetate 形成產物 (Z)-6-(2-bromo-2-phenylvinyl)-4-hydroxy-2,4-diphenyl-3-azabicyclo [3.1.0] hex-2-ene-1,5-dicarbonitrile。以及對 (Z)-3-bromo-3-phenylacrylaldehyde、3-oxo-3-phenylpropanenitrile進行官能基的取代，檢測官能基對反應條件的影響。

The first half of the thesis is the preface, which mainly introduces the research value of 3-azabicyclo[3.1.0]hexane derivatives as drugs and the synthesis methods of other teams through searching past literature, and explains the research motivation and goals.
The second half is to introduce the use of microwave reactors to form (Z)-6-(2-bromo-2 -phenylvinyl)-4-hydroxy-2,4-diphenyl-3-azabicyclo [3.1.0] hex-2-ene-1,5-dicarbonitrile, and for (Z)-3-bromo-3-phenylacrylaldehyde, 3- oxo-3-phenylpropanenitrile was used to replace the functional group, and the tolerance of the reaction conditions to the functional group was tested.

(1) Fritz, S. P.; Matlock, J. V.; McGarrigle, E. M.; Aggarwal, V. K. Efficient synthesis of cyclopropane-fused heterocycles with bromoethylsulfonium salt. Chemistry 2013, 19, 10827-10831.
(2) Wirth, T.; Schmuck, K.; Tietze, L. F.; Sieber, S. A. Duocarmycin analogues target aldehyde dehydrogenase 1 in lung cancer cells. Angew Chem Int Ed Engl 2012, 51, 2874-2877.
(3) S Gomi, D. I., H Nakamura, H Naganawa, F Yamashita, K Hotta, S Kondo, Y Okami, H Umezawa, Y Iitaka. Isolation and structure of a new antibiotic, indolizomycin, produced by a strain SK2-52 obtained by interspecies fusion treatment. J. Antibiot 1984, 37, 1491-1494.
(4) Norris, T.; Braish, T. F.; Butters, M.; DeVries, K. M.; Hawkins, J. M.; Massett, S. S.; Rose, P. R.; Santafianos, D.; Sklavounos, C. Synthesis of trovafloxacin using various (1α,5α,6α)-3-azabicyclo[3.1.0]hexane derivatives. Journal of the Chemical Society, Perkin Transactions 1 2000, 1615-1622.
(5) F. George Njoroge, K. X. C., Neng-Yang Shih, and John J. Piwinski. Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. Acc. Chem. Res. 2008, 41, 50–59.
(6) Feng Xu, J. A. M., Bryon Simmons, Edward Corley, Kenneth Fitch, Sandor Karady, and David Tschaen. Stereocontrolled Synthesis of Trisubstituted Cyclopropanes:  Expedient, Atom-Economical, Asymmetric Syntheses of (+)-Bicifadine and DOV21947. Org. Lett. 2006, 8, 3885–3888.
(7) D D Schoepp 1, B. G. J., R A Wright, C R Salhoff, N G Mayne, S Wu, S L Cockerman, J P Burnett, R Belegaje, D Bleakman, J A Monn. LY354740 is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate Receptors. Neuropharmacology 1997, 36, 1-11.
(8) Kaur, K.; Aeron, S.; Bruhaspathy, M.; Shetty, S. J.; Gupta, S.; Hegde, L. H.; Silamkoti, A. D.; Mehta, A.; Chugh, A.; Gupta, J. B.; et al. Design, synthesis and activity of novel derivatives of oxybutynin and tolterodine. Bioorg Med Chem Lett 2005, 15, 2093-2096.
(9) Ren, X.; Chandgude, A. L.; Fasan, R. Highly Stereoselective Synthesis of Fused Cyclopropane-gamma-Lactams via Biocatalytic Iron-Catalyzed Intramolecular Cyclopropanation. ACS Catal 2020, 10, 2308-2313.
(10) Jing, C.; Jones, B. T.; Adams, R. J.; Bower, J. F. Cyclopropane-Fused N-Heterocycles via Aza-Heck-Triggered C(sp(3))-H Functionalization Cascades. J Am Chem Soc 2022, 144, 16749-16754.
(11) Richter, M. J. R.; Zecri, F. J.; Briner, K.; Schreiber, S. L. Modular Synthesis of Cyclopropane-Fused N-Heterocycles Enabled by Underexplored Diazo Reagents. Angew Chem Int Ed Engl 2022, 61, e202203221.
(12) Kim, B. R.; Sung, G. H.; Ryu, K. E.; Lee, S. G.; Yoon, H. J.; Shin, D. S.; Yoon, Y. J. Direct synthesis of pyrazoles from esters using tert-butoxide-assisted C-(C=O) coupling. Chem Commun (Camb) 2015, 51, 9201-9204.